Supply of 640,000 doses of the herpes zoster vaccine for the years 2026 and 2027

This contract aims to acquire 640,000 doses of the herpes zoster vaccine for distribution in 2026 and 2027. The vaccine is intended for individuals belonging to nationally agreed-upon target groups who are at risk due to specific health conditions or age, as per the recommendations of the Directorate-General for Public Health included in the lifelong vaccination calendar for the Community of Madrid for 2025. As these supplies fall under Article 16.3.a) of the Public Sector Contracts Law (L.C.S.P.), the quantities proposed for award are estimates. The actual delivery will be contingent upon the needs of the Directorate-General for Public Health. This procurement is essential for the public health strategy to prevent and manage herpes zoster infections within the specified population groups. Bidders are expected to provide proposals that meet the required quality standards and delivery schedules. The tender process will ensure the availability of this critical vaccine to protect vulnerable populations. Further details on technical specifications, evaluation criteria, and submission procedures are available in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Vaccines. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 77.0 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.